No Chart Data Available
No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹66Prev. Close
₹64.86Turnover(Lac.)
₹104.6Day's High
₹66.01Day's Low
₹62.852 Week's High
₹10052 Week's Low
₹31.35Book Value
₹47.87Face Value
₹10Mkt Cap (₹ Cr.)
182.52P/E
50.72EPS
1.26Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 33.49 | 32.99 | 30.02 | 27.7 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 105 | 99.79 | 87.39 | 85.94 |
Net Worth | 138.49 | 132.78 | 117.41 | 113.64 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 348.41 | 300.08 | 349.34 | 395.96 |
yoy growth (%) | 16.1 | -14.1 | -11.77 | 60.94 |
Raw materials | -337.79 | -290.18 | -337.36 | -382.98 |
As % of sales | 96.95 | 96.69 | 96.56 | 96.72 |
Employee costs | -0.39 | -0.39 | -0.38 | -0.33 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 8.3 | 7.24 | 8.19 | 7.97 |
Depreciation | -0.92 | -0.89 | -0.71 | -0.64 |
Tax paid | -1.78 | -1.44 | -2.01 | -2.5 |
Working capital | 6.66 | 26.65 | 23.78 | 5.56 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 16.1 | -14.1 | -11.77 | 60.94 |
Op profit growth | 43.51 | -57.69 | -20.51 | 848.64 |
EBIT growth | 18.89 | -10.71 | -17.84 | 248.55 |
Net profit growth | 12.44 | -6.21 | 12.85 | 324.54 |
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,700.7 | 87.3 | 4,08,018.91 | 564.22 | 0.94 | 4,511.27 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,355.5 | 67.13 | 1,68,751.74 | 696 | 0.47 | 2,660 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,003.7 | 63.51 | 1,35,542.32 | 597 | 0.15 | 2,707 | 249.82 |
Cipla Ltd CIPLA | 1,434.5 | 22.29 | 1,15,882.86 | 1,210.53 | 1.12 | 4,495.16 | 411.56 |
Lupin Ltd LUPIN | 2,195.9 | 18.79 | 1,00,267.34 | 1,357.35 | 0.55 | 3,852.79 | 595.98 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman / Executive Director / Managing Director
Mihir R Ghatalia
E D & Wholetime Director
Nimit R Ghatalia
Non-Exec & Non-Independent Dir
BINA RAJESH GHATALIA
Independent Non Exe. Director
Chetan K Mehta
Independent Non Exe. Director
Lalit R Tulsiani
Independent Non Exe. Director
Anil Mandal
Company Sec. & Compli. Officer
KAILASH CHAND JETHLIA
E-34 MIDC Tarapur,
Boisar,
Maharashtra - 401506
Tel: 91-22-23455543
Website: http://www.aareydrugs.com
Email: investorgrievance@aareydrugs.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: https://in.mpms.mufg.com
Email: rnt.helpdesk@in.mpms.mufg.com
Summary
Aarey Drugs & Pharmaceuticals Ltd was originally incorporated on May 15, 1990 as a private limited company in Mumbai with the name Niharika Textiles & Chemicals Pvt Ltd. The company was originally pro...
Read More
Reports by Aarey Drugs & Pharmaceuticals Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.